Note 10.  Subsequent Events

Issuance of Convertible Notes

Subsequent to the period, the Company issued convertible notes to purchase a total of 16,540,000 shares of common stock to accredited investors for gross proceeds of $165,400 at a price per share of $0.01. No solicitation was used in the offering. The Company relied on the exemption from registration available under Section 4(a)(2) of the 1933 Act and/or Rule 506(b) of Regulation D promulgated under the 1933 Act with respect to transactions by an issuer not involving any public offering. No commissions were paid in connection with these issuances of notes. 

Private Placement

On April 30, 2026, the Company issued 2,100,000 shares of common stock to accredited investors in a private placement for gross proceeds of $21,000  at a price per share of $0.01. No solicitation was used in the offering. The Company relied on the exemption from registration available under Section 4(a)(2) of the 1933 Act and/or Rule 506(b) of Regulation D promulgated under the 1933 Act with respect to transactions by an issuer not involving any public offering. No commissions were paid in connection with these issuances of securities.

Warrants and Options

On September 21, 2026, the Company issued 500,000 shares of common stock upon the exercise of 500,000 warrants at an exercise price of $0.01 per share, for total proceeds of $5,000. The warrants had been exercised prior to their expiration date of April 11, 2026.

Between April 2 and July 25, 2026, 4,000,000 warrants expired.

On October 26, 2026, 500,000 options expired.